BRIEF published on 02/20/2026 at 06:35, 2 hours 51 minutes ago Siegfried AG affiche une forte croissance financière malgré les difficultés Performance Financière Stratégie De Croissance Investissement Stratégique Efficacité Opérationnelle Perspectives 2026
BRIEF published on 02/20/2026 at 06:35, 2 hours 51 minutes ago Siegfried AG Exhibits Strong Financial Growth Amid Challenges Growth Strategy Financial Performance Operational Efficiency Strategic Investment 2026 Outlook
PRESS RELEASE published on 02/20/2026 at 06:30, 2 hours 56 minutes ago Siegfried delivers strong profitability and continued growth Siegfried reports strong financial performance in 2025, achieving profitable growth and strategic acquisitions. Core EBITDA margin exceeded 23% Financial Performance CORE EBITDA Margin Profitable Growth Strategic Acquisitions Siegfried
BRIEF published on 02/05/2026 at 06:35, 15 days 2 hours ago Siegfried AG annonce les nominations à son conseil d'administration Industrie Pharmaceutique Nominations Au Conseil D'administration Siegfried AG Thomas Wozniewski Karl Petersson
BRIEF published on 02/05/2026 at 06:35, 15 days 2 hours ago Siegfried AG Announces Board of Directors Nominations Pharmaceutical Industry Board Nominations Siegfried AG Thomas Wozniewski Karl Petersson
PRESS RELEASE published on 02/05/2026 at 06:30, 15 days 2 hours ago Changes to Siegfried's Board of Directors Siegfried announces nomination of Thomas Wozniewski and Karl Petersson to the Board of Directors. Changes in leadership at the Siegfried AG Board Of Directors Leadership Siegfried Thomas Wozniewski Karl Petersson
BRIEF published on 01/27/2026 at 06:35, 24 days 2 hours ago Siegfried augmente la capacité de production de substances médicamenteuses aux États-Unis Marché Pharmaceutique Croissance Et Rentabilité Stratégie EVOLVE+ Acquisition De Siegfried Capacités Pharmaceutiques Des États-Unis
BRIEF published on 01/27/2026 at 06:35, 24 days 2 hours ago Siegfried Expands US Drug Substance Capacity Pharmaceutical Market Growth And Profitability EVOLVE+ Strategy Siegfried Acquisition US Drug Capacity
PRESS RELEASE published on 01/27/2026 at 06:30, 24 days 2 hours ago Siegfried to acquire high-quality small molecules drug substance capacity in the US Siegfried, a global CDMO, acquires Noramco Group and Extractas Bioscience for small molecules drug substance capacity in US, strengthening presence and expanding capabilities Acquisition CDMO US Siegfried Small Molecules
BRIEF published on 11/17/2025 at 07:05, 3 months 3 days ago Siegfried AG Announces CFO Transition Pharmaceutical Industry CFO Transition Siegfried AG Tania Micki Reto Suter
Published on 02/20/2026 at 01:30, 7 hours 56 minutes ago BWR Exploration Inc. And Electro Metals and Mining Inc. Provide Financing and Transaction Update
Published on 02/20/2026 at 00:30, 8 hours 56 minutes ago CoTec Holdings Corp. Publishes Updated Corporate Presentation
Published on 02/19/2026 at 23:55, 9 hours 31 minutes ago Snipp Interactive Inc. Enters Into a $4.5 Million Secured Convertible Debenture Financing Led by Shen Capital
Published on 02/19/2026 at 23:00, 10 hours 26 minutes ago Galway Metals Announces Filing of NI 43-101 Technical Report for Previously Announced Estrades Preliminary Economic Assessment
Published on 02/19/2026 at 21:30, 11 hours 56 minutes ago Algo Grande Copper Announces Upsizing of Private Placement of Common Shares
Published on 02/20/2026 at 09:00, 26 minutes ago PL BioScience Signs Exclusive Japanese Distribution Agreement with Summit Pharmaceuticals International
Published on 02/20/2026 at 07:00, 2 hours 26 minutes ago EQS-Adhoc: BB Biotech AG publishes its 2025 annual report
Published on 02/20/2026 at 07:30, 1 hour 56 minutes ago Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan
Published on 02/20/2026 at 07:30, 1 hour 56 minutes ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 1 hour 56 minutes ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 1 hour 56 minutes ago EURAZEO FINALISE LA CESSION D’EX NIHILO A L CATTERTON
Published on 02/20/2026 at 07:30, 1 hour 56 minutes ago EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON
